Pritish Kumar Panda
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 6
- Electrospun Nanofibers in Biomedical Applications 1
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Sanjay Jain (13 shared papers)Ankita Tiwari (10 shared papers)Shivani Saraf (11 shared papers)Amit Verma (10 shared papers)Ankit Jain (10 shared papers)Govind P. Agrawal (1 shared paper)Om Prakash Katare (1 shared paper)Gajanand Sharma (1 shared paper)
- Journals
- Journal of Drug Delivery Science and Technology (3 papers)Expert Opinion on Drug Delivery (2 papers)International Journal of Pharmaceutical Investigation (2 papers)International Journal of Biological Macromolecules (1 paper)Current Drug Delivery (1 paper)
- Partner nations
- India
In The Last Decade
Pritish Kumar Panda
15 papers receiving 412 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 109
- Biomaterials 155
- Molecular Medicine 19
- Rheumatology 36
- Ophthalmology 18
Countries citing papers authored by Pritish Kumar Panda
This map shows the geographic impact of Pritish Kumar Panda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritish Kumar Panda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritish Kumar Panda more than expected).
Fields of papers citing papers by Pritish Kumar Panda
This network shows the impact of papers produced by Pritish Kumar Panda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritish Kumar Panda. The network helps show where Pritish Kumar Panda may publish in the future.
Co-authors
The 17 scholars most cited alongside Pritish Kumar Panda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 176 | |
| 2 | 2020 | 51 | |
| 3 | 2019 | 44 | |
| 4 | 2019 | 38 | |
| 5 | 2019 | 28 | |
| 6 | 2022 | 17 | |
| 7 | 2019 | 14 | |
| 8 | 2023 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2024 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2024 | 0 |
About Pritish Kumar Panda
Pritish Kumar Panda is a scholar working on Biomaterials, Molecular Biology, Pharmaceutical Science, Biomedical Engineering and Oncology, having authored 18 papers that have together received 420 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Advanced Drug Delivery Systems (4 papers), RNA Interference and Gene Delivery (4 papers), Ocular Surface and Contact Lens (2 papers), Drug Solubulity and Delivery Systems (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Electrospun Nanofibers in Biomedical Applications (1 paper). The work is most often cited by research in Pharmaceutical Science (109 citations), Biomaterials (155 citations), Molecular Medicine (19 citations), Rheumatology (36 citations) and Ophthalmology (18 citations). Pritish Kumar Panda has collaborated with scholars based in India. Frequent co-authors include Sanjay Jain, Ankita Tiwari, Shivani Saraf, Amit Verma, Ankit Jain, Govind P. Agrawal, Om Prakash Katare, Gajanand Sharma, Sarjana Raikwar and Anubhav Dubey. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Expert Opinion on Drug Delivery, International Journal of Pharmaceutical Investigation, International Journal of Biological Macromolecules and Current Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.